About Iterative Health
Iterative Health is a company based in Cambridge (United States) founded in 2017 by Jonathan Ng. Iterative Health has raised $270.52 million across 5 funding rounds from investors including Lilly, Micron Technology and Clearlake Capital Group. The company has 75 employees as of December 31, 2021. Iterative Health has completed 2 acquisitions, including CRSG and Precision Research. Iterative Health offers products and services including Clinical Trial Optimization and SKOUT. Iterative Health operates in a competitive market with competitors including Alimetry, RNT Health Insights, Suzhou Huiwei Intelligent Medical Technology, Cosmo IMD and DigestAID, among others.
- Headquarter Cambridge, United States
- Employees 75 as on 31 Dec, 2021
- Founders Jonathan Ng
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iterative Health
Iterative Health offers a comprehensive portfolio of products and services, including Clinical Trial Optimization and SKOUT.
Platform to optimize and accelerate GI clinical trials
Real-time AI tool for colorectal cancer screening and surveillance
People of Iterative Health
Unlock access to complete
Funding Insights of Iterative Health
Iterative Health has successfully raised a total of $270.52M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $77 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Iterative Health
Iterative Health has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Lilly, Micron Technology and Clearlake Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lower and mid-market investments are managed through private equity strategies.
|
Locked | Locked | Locked | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Locked | Locked | Locked | |
|
Provider of venture capital investments across planetary, human, and economic health
|
Locked | Locked | Locked |
Investor details for Iterative Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Iterative Health
Iterative Health has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CRSG and Precision Research.
Investment portfolio details for Iterative Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical research services are provided for patients and medical practices.
|
Locked | Locked | 2019 | Locked | |
|
Provider of branding and market research services
|
Locked | Locked | 1959 | Locked |
Complete acquisition details for Iterative Health
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Iterative Health
Detailed financials for Iterative Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iterative Health Comparisons
Peer comparison for Iterative Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Iterative Health
Iterative Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alimetry, RNT Health Insights, Suzhou Huiwei Intelligent Medical Technology, Cosmo IMD and DigestAID, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive device for detecting gastric disorders is provided.
|
|
| Locked | Locked | Locked |
Platform offering an AI assisted tool to aid endoscopists
|
|
| Locked | Locked | Locked |
AI-based diagnostic systems for digestive diseases are provided.
|
|
| Locked | Locked | Locked |
Develops AI software and hardware for intelligent medical devices in healthcare.
|
|
| Locked | Locked | Locked |
Develops AI technologies for detecting digestive lesions and endoscopy tools.
|
Detailed competitors of Iterative Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iterative Health
Complete news archive for Iterative Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iterative Health
Iterative Health was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Iterative Health is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Jonathan Ng is the current CEO of Iterative Health. They have also founded this company.
Iterative Health is a funded company, having raised a total of $270.52M across 5 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Iterative Health is 75.
Provider of AI-based device for endoscopic images of gastroenterological diseases. The platform interprets endoscopic pictures and other forms of data using machine learning and computer vision, allowing clinicians to better diagnose patients with possible GI disorders. SKOUT is a polyp detection system that employs artificial intelligence to assist gastroenterologists in detecting more adenomas during colonoscopy.
Iterative Health's top competitors include Alimetry, RNT Health Insights and Suzhou Huiwei Intelligent Medical Technology.
Iterative Health offers Clinical Trial Optimization and SKOUT.
Iterative Health has made 2 acquisitions, including CRSG, and Precision Research.
Iterative Health has 20 investors. Key investors include Lilly, Micron Technology, Clearlake Capital Group, Insight Partners, and Obvious Ventures.